Ar-r15896ar a low affinity use-dependent nmda antagonist is protective in a primate model of stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 9, Issue 6, 2000, Pages 303-312

  Marshall, Jonathan W B ^a,b   Jones, Ellen J ^a,b   Duffin, Katherine J ^a,b   Curry, Stephen H ^a,b   Ridley, Rosalind M ^a,b  

^a UK   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Monkeys; Neglect; NMDA antagonist

Indexed keywords

LANICEMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEPTH PERCEPTION; DRUG TOLERABILITY; HISTOPATHOLOGY; MARMOSET; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE;

EID: 0033653388     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2000.18738     Document Type: Article

References (24)

1. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
2. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia
3. Protective effect of the glutamate antagonist MK-801 in focal cerebral ischemia in the cat
4. Focal cerebral ischaemia in the cat: Treatment with the glutamate antagonist MK-801 after induction of ischaemia
5. (S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride- a low affinity uncompetitive N-methyl-D-aspartic acid antagonist is effective in rodent models of global and focal ischemia
6. Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion
7. Remacemide hydrochloride and ARL 15896AR lack abuse potential: Additional differences from other uncompetitive NMDA antagonists
8. Effects of anticonvulsants in a novel operant learning paradigm in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents
9. Assessment of functional impairment following permanent middle cerebral artery occlusion in a non-human primate species
10. The low affinity use dependent NMDA receptor anatagonist AR-R 15896AR: An update of progress in stroke
11. AR-R15896AR in patients with acute stroke: A dose finding study
12. [S]-AR-R 15896AR-A novel anticonvulsant: Acute safety pharmacokinetic and pharmacodynamic properties
13. Clomethiazole Protects against hemineglect in a primate model of stroke
14. Functional benefit from clomethiazole treatment after focal cerebral ischaemia in a non-human primate species
15. Patterns of neglect dissociation
16. The brain of the common marmoset (Callithrix jacchus): A stereotaxic atlas
17. Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats
18. Hypothermia but not the N-methyl-D-aspartate antagonist MK-801 attenuates neuronal damage in gerbils subjected to transient global ischemia
19. MK-801 reduced cerebral ischemic injury by inducing hypothermia
20. The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia
21. Prospects for the rehabilition of unilateral neglect
22. The anatomy of unilateral neglect after right-hemisphere stroke lesions. A clinical/CT-scan correlation study in man
23. Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia
24. ARR15896AR reduces cerebral infarction volumes after focal ischemia in cats